DoD FY11 Prostate Cancer Population-Based Research Award

The summary for the DoD FY11 Prostate Cancer Population-Based Research Award Federal Grant is detailed below. It contains information such as the Catalog of Federal Domestic Assistance (CFDA) number, who is eligible for the grant, how much grant money will be awarded, important deadlines, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed in the Grant Announcement Contact section. If these sections are incomplete, please visit the website of the government agency that is offering this grant.


	Federal Grant Title:	DoD FY11 Prostate Cancer Population-Based Research Award
	CFDA Number:	12.420
	CFDA Description:	Military Medical Research and Development
	Federal Agency Name:	Dept of the Army USAMRAA
	Category of Funding Activity:	Science and Technology
	Category Explanation:	Information not provided
	Opportunity Category:	Discretionary
	Funding Opportunity Number:	W81XWH-11-PCRP-PBRA
	Document Type:	Grants Notice
	Funding Instrument Type:	Cooperative Agreement Grant
	Posted Date:	Apr 21, 2011
	Creation Date:	Apr 21, 2011
	Original Closing Date for Applications:	Jun 08, 2011
	Current Closing Date for Applications:	Jun 08, 2011
	Archive Date:	Jul 08, 2011
	Expected Number of Awards:	3
	Estimated Total Program Funding:	2,900,000
	Federal Grant Award Ceiling:	Information not provided
	Federal Grant Award Floor:	Information not provided
	Cost Sharing or Matching Requirement:	No

Applicants Eligible for this Grant: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Additional Information on Eligibility: Information not provided
Grant Description: The PCRP Population-Based Research Award mechanism was first offered as the Population-Based Idea Development Award in FY09. Since then, 51 applications have been received, and 3 have been recommended for funding. The Population-Based Research Award mechanism supports high-impact, population-based approaches to prostate cancer research. Applications should clearly demonstrate the potential of the study to contribute significantly to the elimination of death and suffering from prostate cancer. The overall goal of this award is to generate unique information and/or tools that can only be achieved from the perspective of systematic studies of a defined patient population. A robust statistical plan is required and should be supported with requisite statistical expertise in the study team. All applications for the Population-Based Research Award are highly recommended to address one of the FY11 PCRP overarching challenges. The PCRP seeks to fund projects from the wide spectrum of basic to clinical research; however, if the proposed project does not address one of the overarching challenges, the application should provide a description to justify how the project will nevertheless address a critical need in the field of prostate cancer research and/or patient care. Applications may propose retrospective, prospective, case control, cohort, or other population-based study designs (including the use of biospecimens and data from established retrospective databases), provided the proposed sample is of sufficient size to demonstrate statistical significance. The study should address a well developed hypothesis that is conceptually sound and specific for prostate cancer. The statistical expertise of the study team should be clearly described and evident in the study plan. Applicants are expected to provide documentation demonstrating access to, and ability to recruit, the appropriate population(s) or patient samples in numbers sufficient to achieve statistical significance. Research proposed under the Population-Based Research Award may include the following topic areas: Biomarkers Predictors of response to therapy Disease aggressiveness Epidemiology/Public Health Genomics (germline or somatic) Health disparity Molecular genetics Risk prediction Research involving human subject use is permitted under this funding opportunity, but is restricted to studies without clinical trials; however, correlative studies, including studies with populations from existing clinical trials, are allowed. A clinical trial is defined as a prospective accrual of human subjects where an intervention (e.g., device, drug, biologic, surgical procedure, rehabilitative modality, behavioral intervention or other) is tested on a human subject for a measurable outcome with respect to exploratory information, safety, effectiveness and/or efficacy. This outcome represents a direct effect on the human subject of that intervention or interaction. For more information on clinical research, a Human Subject Resource Document is provided at https://cdmrp.org/Program_Announcements_and_Forms/. Principal Investigators (PIs) seeking funding for a clinical trial should consider submitting an application for the FY11 PCRP Clinical Trial Award.
Link to Full Grant Announcement: Information not provided
Grant Announcement Contact: 301-682-5507

CDMRP Help Desk [help@cdmrp.org]
Similar Government Grants: • DOD FY11 Breast Cancer Research Program Clinical Translational Research Award; • DoD Peer Reviewed Orthopaedic Technology Development Award; • DoD Peer Reviewed Orthopaedic Translational Research Partnership Award; • DoD Peer Reviewed Orthopaedic Clinical Trial Award; • DoD Post-Traumatic Stress Disorder In-Home Therapy Clinical Trial Award; • FY2006 Deployed War Fighter Protection Research Program; • Department of Defense (DOD) Fiscal Year 2003 (FY03) Breast Cancer Research Program (BCRP)Concept Awa...; • Department of Defense (DOD) Fiscal Year 2004 (FY04) Breast Cancer Research Program (BCRP) Innovator ...; • Department of Defense (DOD) FY04 Breast Cancer Research Program (BCRP) Concept Award (CA); • Department of Defense Fiscal Year 2004 Breast Cancer Center of Excellence Award (COE)